The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery: a Prospective Double-Blind Randomized Clinical Trial (TeMP - Trial).
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Objective: The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breast Cancer Surgery
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 45
Maximum Age: 74
Healthy Volunteers: f
View:
• The age of the patients is from 45 to 74 years;
• Primary operable breast cancer (BC) without prior chemotherapy;
• Cytologically confirmed breast malignant tumor of IA-IIA stages (T1-2, N0, M0);
• Signed informed consent.
Locations
Other Locations
Russian Federation
Moscow Scientific Clinical Center
RECRUITING
Moscow
Contact Information
Primary
Valerii Subbotin, PhD
subbotin67@mail.ru
+79166122504
Backup
Kristina Kadantseva
kristina161093@gmail.com
+79168306947
Time Frame
Start Date: 2022-03-29
Estimated Completion Date: 2028-04-01
Participants
Target number of participants: 130
Treatments
Experimental: Inhalation anesthesia
Active_comparator: Total intravenous anesthesia
Related Therapeutic Areas
Sponsors
Collaborators: Negovsky Reanimatology Research Institute
Leads: Moscow Clinical Scientific Center